Christopher Papandreou

Dr. Christopher Papandreou

Institut d'Investigació Sanitària Pere Virgili, Reus, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2018 in Diabetes Care
Verified
Journal Article
Open access
PDF file
CRCristina Razquin
Cristina Razquin
ETEstefanía Toledo
Estefanía Toledo
CCClary Clish
Clary Clish
MRMiguel Ruiz-Canela
Miguel Ruiz-Canela
CDCourtney Dennis
Courtney Dennis
MMMiguel A. Martinez-Gonzalez
Miguel A. Martinez-Gonzalez
OBJECTIVE: Specific lipid molecular changes leading to type 2 diabetes (T2D) are largely unknown. We assessed lipidome factors associated with future occurrence of T2D in a population at high cardiovascular risk.RESEARCH DESIGN AND METHODS: We conducted a case-cohort study nested within the PREDIMED trial, with 250 incident T2D cases diagnosed during 3.8 years of median follow-up, and a random sample of 692 participants (639 noncases and 53 overlapping cases) without T2D at baseline. We repeatedly measured 207 plasma known lipid metabolites at baseline and after 1 year of follow-up. We built combined factors of lipid species using principal component analysis and assessed the association between these lipid factors (or their 1-year changes) and T2D incidence.RESULTS: Baseline lysophosphatidylcholines and lysophosphatidylethanolamines (lysophospholipids [LPs]), phosphatidylcholine-plasmalogens (PC-PLs), sphingomyelins (SMs), and cholesterol esters (CEs) were inversely associated with risk of T2D (multivariable-adjusted P for linear trend ≤0.001 for all). Baseline triacylglycerols (TAGs), diacylglycerols (DAGs), and phosphatidylethanolamines (PEs) were positively associated with T2D risk (multivariable-adjusted P for linear trend <0.001 for all). One-year changes in these lipids showed associations in similar directions but were not significant after adjustment for baseline levels. TAGs with odd-chain fatty acids showed inverse associations with T2D after adjusting for total TAGs.CONCLUSIONS: Two plasma lipid profiles made up of different lipid classes were found to be associated with T2D in participants at high cardiovascular risk. A profile including LPs, PC-PLs, SMs, and CEs was associated with lower T2D risk. Another profile composed of TAGs, DAGs, and PEs was associated with higher T2D risk.

7 May 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Christopher PapandreouChristopher Papandreou
Christopher Papandreou
MMMoré Margret
Moré Margret
ABAouatef Bellamine
Aouatef Bellamine
Trimethylamine-N-oxide (TMAO) is generated in a microbial-mammalian co-metabolic pathway mainly from the digestion of meat-containing food and dietary quaternary amines such as phosphatidylcholine, choline, betaine, or L-carnitine. Fish intake provides a direct significant source of TMAO. Human observational studies previously reported a positive relationship between plasma TMAO concentrations and cardiometabolic diseases. Discrepancies and inconsistencies of recent investigations and previous studies questioned the role of TMAO in these diseases. Several animal studies reported neutral or even beneficial effects of TMAO or its precursors in cardiovascular disease model systems, supporting the clinically proven beneficial effects of its precursor, L-carnitine, or a sea-food rich diet (naturally containing TMAO) on cardiometabolic health. In this review, we summarize recent preclinical and epidemiological evidence on the effects of TMAO, in order to shed some light on the role of TMAO in cardiometabolic diseases, particularly as related to the microbiome.

1 June 2018 in Clinical Nutrition
Verified
Journal Article
Closed access
NBNerea Becerra-Tomás
Nerea Becerra-Tomás
ADAndrés Díaz-López
Andrés Díaz-López
NRNúria Rosique-Esteban
Núria Rosique-Esteban
EREmilio Ros
Emilio Ros
PBPilar Buil-Cosiales
Pilar Buil-Cosiales
JTJ. Timiraus-Fernández
J. Timiraus-Fernández

16 April 2018 in Diabetologia
Verified
Journal Article
Closed access
PDF file
MRMiguel Ruiz-Canela
Miguel Ruiz-Canela
MGMarta Guasch-Ferré
Marta Guasch-Ferré
ETEstefanía Toledo
Estefanía Toledo
CCClary Clish
Clary Clish
CRCristina Razquin
Cristina Razquin
MMMiguel A. Martínez-González
Miguel A. Martínez-González

28 June 2017 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
DDDevon A. Dobrosielski
Devon A. Dobrosielski
Christopher PapandreouChristopher Papandreou
Christopher Papandreou
SPSusheel P. Patil
Susheel P. Patil
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó
Obstructive sleep apnoea (OSA) is associated with increased cardiovascular disease (CVD) morbidity and mortality. It is accepted that OSA and obesity commonly coexist. The American Academy of Sleep Medicine recommends dietary-induced weight loss and exercise as lifestyle treatment options for OSA. However, most clinical trials upon which this recommendation is based have focused on establishing the effectiveness of calorie-restricted, often low-fat diets for improving OSA severity, whereas less attention has been given to the means through which weight loss is achieved (e.g.altered dietary quality) or whether diet or exercise mediates the associations between reduced weight, improved OSA severity and the CVD substrate. The current evidence suggests that the benefits of a low-carbohydrate or Mediterranean diet in overweight and obese individuals go beyond the recognised benefits of weight reduction. In addition, exercise has an independent protective effect on vascular health, which may counter the increased oxidative stress, inflammation and sympathetic activation that occur in OSA patients. This review aims to expand our understanding of the effects of diet and exercise on OSA and associated CVD complications, and sets the stage for continued research designed to explore optimal lifestyle strategies for reducing the CVD burden in OSA patients.

20 June 2019 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
XLXiaoran Liu
Xiaoran Liu
YZYan Zheng
Yan Zheng
MGMarta Guasch-Ferré
Marta Guasch-Ferré
MRMiguel Ruiz-Canela
Miguel Ruiz-Canela
ETEstefanía Toledo
Estefanía Toledo
Jordi Salas-SalvadóJordi Salas-Salvadó
Jordi Salas-Salvadó